Exelixis insiders sold shares and filed the required disclosure with the SEC on July 1, 2026.

The entities involved

• Exelixis →

  American biotechnology company

  • A collaboration between Bristol-Myers Squibb and Exelixis is seeking FDA clearance for an IND application regarding combination therapies.07:16
  • Exelixis and uniQure N.V. are competing for investment opportunities as healthcare companies.Fri 17:10
• SEC →

  Slovak company

  • Frontier disclosed major shareholder transactions involving its SVP via an SEC filing on July 27, 2026, while the company is listed on the Nasdaq stock exchange.06:14
  • Ton filed regulatory documents with the SEC and was listed on Nasdaq, with Benzinga reporting on its earnings call.06:00

Related events

• Insider purchase disclosed via SEC filing for Transcontinental Realty Investors, Inc. on August 6, 2026.Aug 7
• Insider transaction disclosed by MediaAlpha, Inc. via an SEC filing on November 1, 2026.Thu 04:59
• Insider transactions were disclosed in an SEC filing, showing a hedge fund bought a new stake in Strategy Inc stock.Oct 25
• Insider transaction disclosed in SEC filing concerning NexPoint Residential Trust on October 1, 2026.Oct 6
• Wholesale Club disclosed insider transactions to the SEC.Fri 09:25